Voice of America
08 May 2021, 00:05 GMT+10
The World Health Organization Friday approved for emergency use a COVID-19 vaccine created by China's state-owned drug maker Sinopharm, the sixth vaccine approved by the organization, and the first produced by a non-Western drug maker.
At the agency's regular briefing, WHO Director-General Tedros Adhanom Ghebreyesus said the WHO Strategic Advisory Group of Experts on Immunization (SAGE) reviewed the available data and recommended the vaccine for adults 18 years and older, with a two-dose schedule.
Emergency use listing by the WHO is a signal to nations worldwide the vaccine can be quickly approved and imported for distribution, especially those without an international standard regulator of their own.
Tedros noted the vaccine can also now be included in the WHO-administered COVAX vaccine cooperative, designed to provide vaccines for the world's under-developed nations. The program has been running short of vaccine. Sinopharm vaccine is already being used in many countries around the world.
The WHO has already given emergency approval to COVID-19 vaccines developed by Pfizer-BioNTech, AstraZeneca, Johnson & Johnson and last week, Moderna.
The WHO said it is also considering a second Chinese vaccine for emergency use, produced by Sinovac Biotech, and is expected to decide on it as soon as next week.
Get a daily dose of Argentina Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Argentina Star.
More InformationGENEVA, Switzerland: A new United Nations report alleges that dozens of global corporations are profiting from and helping sustain...
LONDON, UK - Lawmakers in the United Kingdom have voted overwhelmingly to proscribe the direct-action group Palestine Action as a terrorist...
DHARAMSHALA, India: The Dalai Lama is set to address a significant three-day conference of Buddhist leaders this week, coinciding with...
WASHINGTON, D.C.: In a significant ruling last week, the U.S. Supreme Court upheld a Texas law requiring age verification for users...
ISTANBUL/PARIS/BRUSSELS: As searing temperatures blanket much of Europe, wildfires are erupting and evacuation orders are being issued...
VENICE, Italy: Over the weekend, hundreds of protesters marched through the narrow streets of Venice to voice their opposition to billionaire...
NEW YORK, New York -U.S. stock markets closed with broad gains on Thursday, led by strong performances in U.S. tech stocks, while European...
LONDON/STOCKHOLM: The Persson family is ramping up its investment in the H&M fashion empire, fueling renewed speculation about a potential...
PARIS, France: L'Oréal is making a fresh play in the booming premium haircare segment with a new acquisition. The French beauty conglomerate...
MENLO PARK, California: Robinhood is giving European investors a new way to tap into America's most prominent tech names — without...
NEW YORK, New York - U.S. stocks diverged on Wednesday for the second day in a row. The Standard and Poor's 500 hit a new all-time...
NEW YORK CITY, New York: The U.S. dollar continues to lose ground, weighed down by growing concerns over Washington's fiscal outlook...